The rising interest in GLP-1 agonists for metabolic health has led to a debate about delivery routes : transdermal systems versus pills . Traditionally , GLP-1 therapies were only available in oral https://deborahnwxz567673.blog-mall.com/41734746/glp-1-transdermal-delivery-systems-vs-oral-medications-which-best-for-you